BOOKMARK
  • Korean|
  • Chinese|
  • Japanese|
  • Vietnamese
본문내용 바로가기

Aju Business Daily

SEARCH
  • ECONOMY
  • ENTERTAINMENT
  • IT
  • South Korea
  • North Korea
  • WORLD
  • SPORTS
  • LIFESTYLE
  • AUTO MOTIVE
  • OPINION
  • PEOPLE
  • MILITARY
Home > Health > article

Semiconductor-based fast test kit using saliva able to debut in March: science minister

Lim Chang-won Reporter(cwlim34@ajunews.com) | Posted : Febuary 22, 2021, 17:19 | Updated : Febuary 22, 2021, 17:19
  • 트위터
  • 페이스북
  • 웨이보

[Yonhap News Photo]


SEOUL -- A semiconductor-based fast test kit capable of diagnosing COVID-19 with saliva in three minutes is able to make its commercial debut probably in March, South Korea's science minister said. Health officials have hinted at adopting easy sampling using saliva, although they still stick to a molecular biology technique that amplifies specific DNA samples for accuracy.

South Korea is trying to unveil a "completely new concept" of test devices through joint work by hospitals, research groups and companies, Science and ICT Minister Choi Ki-young said in a news conference on February 22. "I think there is enough time to introduce it by March," he said, referring to a test device using saliva.

For quick and extensive tracking, the Korea Centers for Disease Control and Prevention (KCDC) has suggested that it would consider adopting a combination of easy saliva sampling and nasopharyngeal swabs for the real-time polymerase chain reaction (PCR) method that amplifies specific DNA samples. KCDC director Jeong Eun-kyeong regards PCR testing based on nasopharyngeal swabs as the most accurate method, but she has said that her agency would consider adopting easy sampling.

South Korean pharmaceutical companies have a roadmap to release vaccines in early 2022, Choi said. "I think it will be possible to develop a home-made COVID-19 vaccine early next year unless there are special variables," he said, pledging full government support for the development of domestic vaccines and cures. "We don't know how long the effect of vaccines will last and there are many variants, so we can't rely on foreign products, vaccines. In preparation for this, it is imperative to have a domestic vaccine and treatment development platform."

The Seoul government hopes to vaccinate about 70 percent of the entire population. South Korea has approved clinical trials for three DNA vaccines, three recombinant vaccines and one viral vector vaccine. SK Bioscience has promised to develop safe vaccines through the protein culture and refining platform of an antigen produced with gene recombination technology.

  • Lim Chang-won Reporter
  • email : cwlim34@ajunews.com
© Aju Business Daily & www.ajunews.com Copyright: All materials on this site may not be reproduced, distributed, transmitted, displayed, published or broadcast without the authorization from the Aju News Corporation.
  • twitter
  • facebook
  • weibo
  • link copy
  • LIST
  • TOP

Related news

  • .Hanmi Pharmaceutical unveils quick COVID-19 antigen test kit.
    Hanmi Pharmaceutical unveils quick COVID-19 antigen test kit
  • . Celltrion revises deal with U.S. client to ship new rapid COVID-19 antigen test kit.
    Celltrion revises deal with U.S. client to ship new rapid C…
  • .Sugentechs antibody test kit wins state approval for domestic use.
    Sugentech's antibody test kit wins state approval for domest…
  • .Anti-epidemic center considers introducing rapid antigen inspection.
    Anti-epidemic center considers introducing rapid antigen ins…

Real Time Photo News

  • .[TRAVEL] North Chungcheong Province launches Wellness Trip for body and mind.

    [TRAVEL] North Chungcheong Province launches 'Wellness Trip' for body and mind

  • .BLACKPINK member Rosé reveals name of upcoming solo album title track thru teaser video.

    BLACKPINK member Rosé reveals name of upcoming solo album title track thru teaser video

  • .Girl band (G)I-DLE shrinks size to five members after school bullying controversy.

    Girl band (G)I-DLE shrinks size to five members after school bullying controversy

  • .Singer-actress IU reveals release schedule for album LILAC.

    Singer-actress IU reveals release schedule for album 'LILAC'

  • .S. Korea to build state-run K-pop concert hall for unaffordable online performances .

    S. Korea to build state-run K-pop concert hall for unaffordable online performances

Latest News

more+

  • [TRAVEL] North Chungcheong Province launches 'Wellness Trip' for body and mind
  • Kakao Mobility jumps into pet taxi business thru acquisition of domestic startup
  • Homebodies advised to use safe lactobacillus kit for home-made yogurt
  • LG Electronics wins patent lawsuit in Germany against China's TCL
  • Samsung shipyard wins new order for five LNG-powered container ships
Aju Business Daily
  • ABOUT US
  • CONTACT US
  • PRIVACY STATEMENT
  • Copyright Policy

Address : Aju News Corporation LEEMA Building, 11th floor, 42, Jong-ro 1-gil, Jongno-gu, Seoul.    Mail : swatchsjp@ajunews.com

Copyright ⓒ 2016 By Ajunews Corporation, All Rights Reserved.

Mobile view